User profiles for E. Farrow
Emily FarrowAssistant Professor, UMKC School of Medicine Verified email at cmh.edu Cited by 6073 |
Recent advances in renal phosphate handling
Phosphate is critical for the maintenance of skeletal integrity, is a necessary component of
important biomolecules, and is central to signal transduction and cell metabolism. It is …
important biomolecules, and is central to signal transduction and cell metabolism. It is …
Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units
…, RJ Grocock, EH Margulies, EG Farrow… - Science translational …, 2012 - science.org
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease
presentations are often undifferentiated at birth. More than 3500 monogenic diseases have …
presentations are often undifferentiated at birth. More than 3500 monogenic diseases have …
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders
SE Soden, CJ Saunders, LK Willig, EG Farrow… - Science translational …, 2014 - science.org
Neurodevelopmental disorders (NDDs) affect more than 3% of children and are attributable
to single-gene mutations at more than 1000 loci. Traditional methods yield molecular …
to single-gene mutations at more than 1000 loci. Traditional methods yield molecular …
Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings
Background Genetic disorders and congenital anomalies are the leading causes of infant
mortality. Diagnosis of most genetic diseases in neonatal and paediatric intensive care units (…
mortality. Diagnosis of most genetic diseases in neonatal and paediatric intensive care units (…
[HTML][HTML] Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome
…, LD Smith, NA Miller, AM Atherton, EG Farrow… - Genomics, 2013 - Elsevier
Mitochondrial diseases are notoriously difficult to diagnose due to extreme locus and allelic
heterogeneity, with both nuclear and mitochondrial genomes potentially liable. Using exome …
heterogeneity, with both nuclear and mitochondrial genomes potentially liable. Using exome …
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
EG Farrow, X Yu, LJ Summers… - Proceedings of the …, 2011 - National Acad Sciences
Autosomal dominant hypophosphatemic rickets (ADHR) is unique among the disorders
involving Fibroblast growth factor 23 (FGF23) because individuals with R176Q/W and R179Q/W …
involving Fibroblast growth factor 23 (FGF23) because individuals with R176Q/W and R179Q/W …
[HTML][HTML] A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases
While the cost of whole genome sequencing (WGS) is approaching the realm of routine
medical tests, it remains too tardy to help guide the management of many acute medical …
medical tests, it remains too tardy to help guide the management of many acute medical …
Cleidocranial dysplasia: a review of clinical, radiological, genetic implications and a guidelines proposal
E Farrow, R Nicot, A Wiss, A Laborde… - Journal of Craniofacial …, 2018 - journals.lww.com
… Address correspondence and reprint requests to Emilie Farrow, MD, Service de
Chirurgie Maxillo-Faciale et Stomatologie Hôpital Roger Salengro, Bd du Professeur Emile …
Chirurgie Maxillo-Faciale et Stomatologie Hôpital Roger Salengro, Bd du Professeur Emile …
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Mice with constitutive activation of parathyroid hormone (PTH) receptor signaling in osteocytes
(DMP1-caPTHR1 transgenic mice) exhibit increased bone mass and remodeling, two of …
(DMP1-caPTHR1 transgenic mice) exhibit increased bone mass and remodeling, two of …
Initial FGF23-mediated signaling occurs in the distal convoluted tubule
EG Farrow, SI Davis, LJ Summers… - Journal of the American …, 2009 - journals.lww.com
Fibroblast growth factor-23 (FGF23), a hormone central to phosphate and vitamin D
metabolism, reduces renal absorption of phosphate by downregulating the sodium-phosphate …
metabolism, reduces renal absorption of phosphate by downregulating the sodium-phosphate …